Literature DB >> 6660861

Correlation of microenvironmental drug concentration with inhibition of growth of microorganisms on surfaces.

E Y Cesar, T Sonobe, W I Higuchi.   

Abstract

Methodologies have been developed to study the concept of microenvironmental drug concentration (C*) near or around microorganisms. C* may be calculated from data on drug release from a depot site by using appropriate diffusion relationships. By following C* and correlating this with the minimum inhibitory concentration (CMIC), one could attempt to predict the effectiveness of an antiplaque agent. When C* is less than CMIC, growth would be expected to occur; when C* is higher than or equal to CMIC, growth would not be expected. Chlorhexidine diacetate was chosen for this study, which used a system involving microorganisms present on the surface of drug-treated hydroxyapatite pellets. CMIC, defined as the lowest concentration to inhibit bacterial growth, was determined independently and under conditions similar to those used in the C* experiments. Surface growth of adhering microorganisms (Streptococcus mutans SL1) was followed by scanning electron microscopy. The parameters used in the calculation of C* were determined independently. Diffusion coefficients of the drugs and the diffusion layer thickness were determined under conditions similar to those employed in the release rate studies. Surface growth was generally found to be inhibited whenever C* was significantly greater than CMIC, and growth occurred whenever C* was significantly smaller than CMIC. These findings demonstrate how C* may determine the action of a topically administered antimicrobial agent and how the various physical and chemical factors play roles in influencing this quantity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660861      PMCID: PMC185412          DOI: 10.1128/AAC.24.6.941

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Dissolution kinetics of cholesterol in simulated bile I: Influence of bile acid type and concentration, bile acid-lecithin ration, and added electrolyte.

Authors:  K H Kwan; W I Higuchi; A M Molokhia; A F Hofmann
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

2.  Influence of variation of pH of chlorhexidine mouth rinses on oral retention and plague-inhibiting effect.

Authors:  P Gjermo; P Bonesvoll; L G Hjeljord; G Rölla
Journal:  Caries Res       Date:  1975       Impact factor: 4.056

3.  A study of the elimination of chlorhexidine from the oral cavity using a new spectrophotometric method.

Authors:  J E Jensen; F Christensen
Journal:  J Periodontal Res       Date:  1971       Impact factor: 4.419

4.  Some antibacterial properties of chlorhexidine.

Authors:  T S Hennessey
Journal:  J Periodontal Res Suppl       Date:  1973

5.  The plaque=inhibiting capacity of 11 antibacterial compounds.

Authors:  P Gjermo; K L Baastad; G Rölla
Journal:  J Periodontal Res       Date:  1970       Impact factor: 4.419

6.  Relationship between plaque-inhibiting effect and retention of chlorhexidine in the human oral cavity.

Authors:  P Gjermo; P Bonesvoll; G Rölla
Journal:  Arch Oral Biol       Date:  1974-11       Impact factor: 2.633

7.  Tracer and mutual diffusion coefficients of proteins.

Authors:  K H Keller; E R Canales; S I Yum
Journal:  J Phys Chem       Date:  1971-02-04

8.  Effects of antibacterial microenvironment on in vitro plaque formation of Streptococcus mutans as observed by scanning electron microscopy.

Authors:  H P Merkle; W I Higuchi
Journal:  Arzneimittelforschung       Date:  1980

9.  Influence of concentration, time, temperature and pH on the retention of chlorhexidine in the human oral cavity after mouth rinses.

Authors:  P Bonesvoll; P Lökken; G Rölla
Journal:  Arch Oral Biol       Date:  1974-11       Impact factor: 2.633

10.  Factors affecting the adsorption of chlorhexidine gluconate by hydroxyapatite.

Authors:  M Hata; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-04       Impact factor: 1.645

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.